Gregory B. Haber

Title: MD, Professor
Position: Professor of Medicine and Biochemistry and Molecular Pharmacology | Chief of Endoscopy, NYU Langone Health | Director of the Center for Advanced Therapeutics and Innovation
Organization: NYU Langone Health
Country: USA

Dr. Haber is one of the world’s foremost experts in clinical care and education in advanced therapeutic endoscopy. Dr. Haber has dedicated himself to the mentorship of the next generation of physicians in these techniques and technologies, having trained more than 50 advanced fellows.
After receiving his medical degree from the University of Toronto, Dr. Haber completed his training in Internal Medicine and Gastroenterology. He subsequently received a Medical Research Council of Canada Grant to do postgraduate research in bile acid metabolism at the Bristol Royal Infirmary, in Bristol, England. He returned to the University of Toronto as a consultant at The Wellesley Hospital and St. Michael’s Hospital where the Advanced Endoscopy Center for the University was established. He was appointed Chief of Gastroenterology at Lenox Hill Hospital from 2004 to 2016. He took his current position at NYU Langone Medical Center on 2016. In 2018, Dr. Haber was honored with the title of Professor of Medicine and Biochemistry and Molecular Pharmacology by NYU Langone Health.

Dr. Haber has contributed over 100 scientific publications and over 150 abstracts, and has given nearly 400 presentations at educational seminars and conferences nationally and internationally. He frequently serves as a course director for educational conferences and in 2010 was the recipient of the American Society for Gastrointestinal Endoscopy’s Master of Endoscopy Award.

His areas of expertise include advanced resection with ESD, EMR, and Full Thickness Resection, along with third space intervention with POEM for achalasia, gastroparesis, and Zenker’s. He has also had a lifelong commitment to pancreatic-biliary disease with ERCP and EUS interventions.